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ABSTRACT 
Pseudomonas aeruginosa is a typical and major human pathogen, it causes numerous risky opportunistic infections like cystic fibrosis, wound 
infection, urinary tract infection, ear infections, endocarditis, nosocomial infections and bacteremia, etc. Furthermore, due to their phenotypic 
variations; identification maybe sometimes harder and consequently which delays their early diagnosis and treatment in infected patients.  
Hence, a quick and accurate method for the identification of P. aeruginosa would be more helpful in their early diagnosis. The present work was 
aimed to use species-specific primer for the rapid and precise identification of P. aeruginosa strains. Multiple drug-resistant strains were 
selected and their genetic variability was studied using ERIC-PCR. The results showed that out of ten P. aeruginosa isolates, eight were found to 
be unique and genetically diverse. 
Keywords: Pseudomonas aeruginosa, ERIC-PCR, MDR. Wound infection, Pus sample. 
 
Article Info: Received 23 June 2019;     Review Completed 09 Aug 2019;     Accepted 14 Aug 2019;     Available online 25 August 2019 
Cite this article as: 
Deepak K, Sivakumar S, Sharmila P, Sivasubramani K, ERIC-PCR: A Molecular Typing Tool for Genotyping Multi Drug 
Resistant Pseudomonas aeruginosa Isolated from the Pus Samples, Journal of Drug Delivery and Therapeutics. 2019; 9(4-
s):1007-1011 http://dx.doi.org/10.22270/jddt.v9i4-s.3712                                                                             
*Address for Correspondence:   





Pseudomonas aeruginosa is an aerobic non-spore 
forming Gram-negative rod-shaped with a remarkably 
adaptable capacity to survive and persist under a broad 
range of environmental conditions 1 (Dworkin et al., 2006). 
Asa common opportunistic human pathogen; acquired from 
both hospital and community settings 2 (Driscoll et al.,2007). 
Also, they found in a variety of aqueous solutions, including 
disinfectants, soaps, ear drops and eye drops, as well as in 
sinks, hot tubes, respiratory equipment and showerheads. P. 
aeruginosa is rarely found in the microbial flora of healthy 
persons but may colonize the gastrointestinal tract of 
hospitalized patients 3 (Brooks et al.,2007). However, the 
taxonomic complexity, uncertain phylogeny, and paucity of 
genomic sequence data of the dozens of species within the 
broad genus Pseudomonas present an obstacle in the 
genotypic identification assays. In the 1980s, a new standard 
for identifying bacteria began to develop. In the laboratories, 
it was shown that the phylogenetic relationship of the 
bacteria and all life-forms, could be determined by 
comparing a stable part of the genetic codes 4, 5 (Tortoli, 
2003 and Woese,1987). Candidates for this area in bacteria 
included the genes that code for the 5S, the 16S (small 
subunit), and the 23S rRNA and the spaces between these 
genes. The part of the DNA now a day most commonly used 
for the taxonomic purpose for the bacteria is the gene-
specific primer 6 (Bottger, 1989).  
Clinical strains of P. aeruginosa resistant to many 
classes of antimicrobial agents, including β-lactams, 
aminoglycosides and fluoroquinolones, are often isolated 7 
(Potronet al.,2015). However, an increase in strains resistant 
to the third- and fourth-generation cephalosporins and 
carbapenems has become a serious clinical problem 
worldwide. The primary cause of cephalosporin resistance in 
P. aeruginosa isolates is the overexpression of the 
chromosomal AmpC enzyme, and the production of the 
Metallo-β-lactamases 8 (Bae et al., 2014 and Kos et al.,2016). 
However, ESBL-positive P. aeruginosa strains that produce 
extended-spectrum-β-lactamases (ESBLs) are frequently 
isolated 9 (Poirelet al.,2010). The features of these enzymes 
are utilized in the phenotypic tests used for the detection of 
ESBL-producing strains. 
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The clinical importance of P. aeruginosa is usually 
associated with its high resistance against antimicrobial 
drugs, and additionally to itsintric resistance to antibiotics, it 
becomes quickly resistant against the antibiotics during the 
treatment10 (Tsutsui et al.,2011). The prevalence of 
multidrug-resistance (MDR) isolates has been increasing 
worldwide and poses a serious problem in hospital settings, 
with a significant rise in patients’ morbidity and mortality12 
(Hocquetet al.,2010). One of the widely used repetitive DNA 
elements in PCR-based genotyping methods is the ERIC PCR 
common to Gram-negative enteric bacteria 13 (Syrmis et 
al.,2004). The present study was designed to investigate the 
genetic diversity of a collection of multidrug-resistant P. 
aeruginosa strains isolated from clinical samples by using 
ERIC-PCR and their species identification. Also, the 
determination of genetic relationships among the resistant 
strains allows mapping the dynamics of infection 
transmission in the region of the study and this will provide 
a better understanding of the epidemiology of the resistant 
strains. 
MATERIAL AND METHODS 
Sample collection 
Seventy clinical isolates were collected from the 
Department of Microbiology, Rajah Muthiah Medical College 
(RMMCH), Chidambaram, Cuddalore District, Tamil Nadu, 
identity of isolates were confirmed using a series of 
microbiological tests such as Gram staining, motility, catalase 
test, oxidase test and standard biochemical tests such as 
indole, methyl red, Voges–Proskauer, citrate, urease, nitrate 
reduction and triple sugar ion tests (Edition, 2013).  
Antibiotic susceptibility test 
The following Antibiotics were used to screen the 
resistance of the isolates. Amikacin (30µg), Aztreonam 
(30µg), Cefepime (30µg), Ceftazidime (30µg), Ciprofloxin 
(5µg), Gentamicin (10µg), Imipenem (10µg), Levofloxacin 
(5µg), Meropenem (10µg), Piperacillin (100 µg), Tobramycin 
(10µg) Norfloxacin (50µg), Ofloxacin (30µg), Cefixime(30µg), 
Tetracycline (10µg).(Hi media, Mumbai). Drug-resistant 
patterns of the bacterial isolates were determined by using 
the Kirby-Bauer disc diffusion method according to CLSI 
guidelines and followed by (Hudzicki, 2009). Pure isolate 
culture was swabbed on the Muller Hinton Agar plate 
(Himedia, Mumbai). Antibiotic discs were dispensed on the 
surface of the seeded agar plates and the plates were 
incubated at 37°C for 18-24 hrs. After that agar plates were 
examined for inhibition of growth and the zone of inhibition 
was measured. 
Among the 70 P. aeruginosa isolates tested for 
antibiotic resistance, 10 strains showed a higher degree of 
resistance to many antibiotics (i.e.) multidrug resistance 
(MDR), so these 10 strains alone were selected for further 
species-specific identification and ERIC-PCR based 
genotyping studies. 
DNA Extraction 
1.5 ml of overnight grown bacterial isolates 
maintained in nutrient broth were transferred to 2 ml of 
microcentrifuge tube and centrifuged at 10,000 x g for 2 min 
and the pellet was collected. The same was repeated for 
another 1.5 ml of culture to harvest enough quantity of cells 
(100 mg). The pellet was washed with 0.9 % saline and was 
suspended in 1 ml of CTAB solution (Cetyltrimethyl 
ammonium bromide buffer (100 mMTris, 1.4 M NaCl, 1.11% 
EDTA and 2% CTAB) was incubated at 60 °C with occasional 
shaking in tightly capped microcentrifuge tubes for 60 min. 
The sample was then extracted with an equal volume of 
phenol-chloroform-isoamyl alcohol (25:24:1) and 
centrifuged for 10 min at 10,000 x g. The top aqueous layer 
was transferred to a new tube. To it, 0.5 volumes of 7.5 M 
ammonium acetate was mixed gently and 2 volumes of 100 
% ice-cold ethanol were added. It was centrifuged for 5 min 
at 5000 x g. The DNA pellet was washed with 70 % ethanol. 
The pellet was air-dried and re-suspended in 25μl of TE 
buffer (pH 8.0) and stored at -20 °C. 
Gene-specific amplification of Pseudomonas aeruginosa 
The gene-specific primers (PA-SS-F 5'- 
GGGGGATCTTCGGACCTCA -3' and PA-SS-R 5'- 
TCCTTAGAGTGCCCACCCG -3') were used for the 
amplification of the 16S rDNA gene-specific fragment. The 
PCR cycling conditions were as follows: an initial 
denaturation for 5 min at 95 ºC, followed by 30 cycles of 
denaturation at 95ºC for 20 secs, annealing at 58ºC for 20 sec 
and extension at 72 ºC for 40 secs and then a final extension 
for 5 min at 72ºC. The 16s rDNA amplification reaction 
mixture (25µl) consists of 2X Amplicon Red master mixes 
(amplicon®) with 10 ng of total genome of each isolate, 10 
pmol of each forward and reverse primer. The amplified PCR 
products were electrophoresed on 1.5% agarose gel. The gel 
was stained in ethidium bromide and photographed with a 
gel documentation system.  
Enterobacterial repetitive intergenic consensus 
polymerase chain reaction (ERIC-PCR) analysis of the 
MDR P. aeruginosa 
ERIC-PCR was performed for a total of 10 MDR P. 
aeruginosa isolates which were resistant to more than one or 
two antibiotics were selected for molecular typing. This 
technique was carried out in a Thermocycler (Agilent 
SureCycler 8800. USA) using the primer ERIC (F): 5ʹ- 
CAGCCATGAACAACTGGTGGCG -3ʹ and ERIC (R): 5ʹ-
TGCTTTGCGCAGGGAAGATTCC 3ʹ following cycle condition: 
initial denaturation 95 °C for 7 min) followed by 30 cycles of 
denaturation (95 °C for 30 sec), annealing (52°C for 1min), 
extension (72 °C for 5 min), and a final cycle of extension at 
72 °C for 15 min. The PCR products were loaded on a 1.5% 
agarose gel (Sigma-Aldrich) at 70 V for 1 hr, and the banding 
patterns were visualized on an ultraviolet illumination. 
ERIC-PCR results analysis Te ERIC patterns were analyzed by 
online data analysis service (inslico.ehu.es). ERIC profiles 
were compared using the Dice coefficient method and 
dendrogram based cluster analysis using by unweighted pair 
group method using arithmetic averages (UPGMA) program. 
RESULTS AND DISCUSSION 
The major public health wellbeing is to find a 
suitable treatment for P. aeruginosa infection considering the 
disturbing patterns of developing drug-resistant to multiple 
antibiotics 21 (Perez et al.,2007). In the present study, 
Pseudomonas aeruginosa isolates collected from clinical 
samples of RMMCH were identified using standard 
biochemical tests. The results showed that all the 70 isolates 
have belonged to Pseudomonas aeruginosa. The 70 strains 
were subjected to antibiotic susceptibility test using the disk 
diffusion method and the results showed that 10 out of 70 
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Figure1: Multidrug resistance profile of selected P. aeruginosa isolates to different antibiotics 
 
Figure 1 shows the multidrug resistance (MDR) 
profiles of selected strains tested against 15 different 
antibiotics. The isolate P. aeruginosa 08 was found to be the 
most resistant among the other 9 MDR isolates i.e. it showed 
resistance to 12 antibiotics and sensitivity was observed 
only to 3 antibiotics namely Meropenam, Cefexime and 
Tobramycin. Nearly 9 out of 10 P. aeruginosa isolates were 
almost resistant to 9 to 10 antibiotics tested. The isolate P. 
aeruginosa 40 isolate showed least resistant among the 
other isolates tested i.e. it was resistant to only 7 antibiotics. 
The ten MDR P. aeruginosa isolates were further 
confirmed by PCR using a species-specific primer. PCR 
amplification yielded a 956bp product for all the MDR 
isolates tested (Figure 2). Similarly, a study was done by 
Spilker et al.,2004 on Pseudomonas sp., found 14 out of 14 
were Pseudomonas aeruginosa24.  
 
 
Figure 2: Gene specific amplification of Pseudomonas aeruginosa showing amplified PCR product of 956bp in1.5 % agarose 
gel. Lane M: 250- 1.5kb bp DNA Ladder, Lanes P: Positive control. Lanes N: Negative control, Lanes 1-10: Species specific 
amplification profile of P. aeruginosa isolates PA01, 2-PA07, PA08, PA13, PA19, PA22, PA40, PA67, PA68 and PA70. 
 
 
Figure3: ERIC-PCR analysis of P. aeruginosa; Lane M: 250- 1.5kb bp DNA Ladder, Lanes 1-10: ERIC profile isolates PA01, 2-
PA07, PA08, PA13, PA19, PA22, PA40, PA67, PA68 and PA70. 
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Figure 4: ERIC-PCR based dendrogram analysis of MDR P. aeruginosa isolates 
 
Among the 10 MCR P. aeruginosa isolates tested for 
genetic diversity and heterogeneity analysis using the ERIC-
PCR and were further sub-typed into 8 types (I-VIII) based 
on ERIC profiles. The similar ERIC-PCR-type (EPT)-1 was 
observed for the isolates PA01, PA07 Cluster-I whereas EPT-
2 was observed for the isolates PA08, PA13 Cluster-II. So, 
they might have originated from the same source or possible 
cross-infection and also eight of the isolates were found to be 
heterogeneous. The remaining genotypes of 3-8 were 
observed as single clones (i.e.) PA19, PA22, PA40, PA67, 
PA68 and PA70 respectively. The isolates in the cluster I and 
Cluster II shared 100% similarity. In each cluster, there were 
two identical isolates found and each of them has formed a 
single clone (Figure 3 and Table 1). 
The results showed that though the gene-specific 
primers specifically identify the Pseudomonas strains, the 
ERIC-PCR genotyping method differentiates the isolates 
more accurately. Hence, the combination of both the 
techniques i.e. species-specific primers with ERIC-PCR would 
be more useful in the precious identification of the 
Pseudomonas species. 
 
Table 1: Genetic similarity coefficient of isolates strain 
Isolate PA01 PA07 PA08 PA13 PA19 PA22 PA40 PA67 PA68 P70 
PA01 1.000          
PA07 1.000 1.000         
PA08 0.711 0.711 1.000        
PA13 0.685 0.685 0.685 1.000       
PA19 0.889 0.889 0.711 0.685 1.000      
PA22 0.889 0.889 0.711 0.685 1.000 1.000     
PA40 0.597 0.597 0.597 0.597 0.597 0.597 1.000    
PA67 0.597 0.597 0.597 0.597 0.597 0.597 0.778 1.000   
PA68 0.833 0.833 0.711 0.685 0.833 0.833 0.597 0.597 1.000  
PA70 0.635 0.635 0.635 0.635 0.635 0.635 0.597 0.597 0.635 1.000 
 
When dealing with MDR pathogens, earlier identification 
and confirmation of the source will be helpful in treating the 
infections easily. Genotypic identification methods would be 
expected to circumvent the problems associated with the 
identification process18 (De-Vos, et al.,1997). In the present 
work, we used a simple molecular typing method ERIC-PCR 
to find the hereditary relatedness among the extremely MDR 
pathogenic isolates of P. aeruginosa isolates and also 
compared each other using ERIC-PCR. The dendrogram 
analysis of the ERIC-PCR profiles showed phylogenetic 
relationships among the MDR P. aeruginosa isolates (Figure 
4). 
ERIC-PCR a PCR based technique utilized for studying P. 
aeruginosa endemicity and being a rapid and cost-effective 
approach tends to be utilized and can give some clues for the 
possible transmission pattern of multidrug-resistant 
pathogens22, 23 (Aljindan et al., 2018 and Ranjbar et al., 
2017). Lim et al 2009 suggest ERIC-PCR and PCR 
amplification with species-specific primer as a good method 
to determine the diversity of P. aeruginosa. Several other 
reports have shown that ERIC-PCR can be an excellent tool 
for the genotypic screening of P. aeruginosa isolates25, 26, 27,  
(Goudarzi et al., 2011 , Dawson et al., 2002, and Inacio et al., 
2014). The present result is in agreement with Khosravi et 
al., 2016 as they observed genetic diversity and 
heterogeneity nature of the MDR P. aeruginosa isolates of 
clinical origin28. 
CONCLUSION  
The ever-increasing antibiotic resistance among P. 
aeruginosa starting from different sources has been proved 
incontestably true in the present study. The high level of 
resistance to multiple drugs tested against the clinical 
isolates of P. aeruginosa suggests that efficient and 
persistent control measures and strict antibiotic policies 
have to be made to combat drug resistance. ERIC-PCR as a 
powerful discriminating tool can be used to analyze the 
diversity and sub-type the P. aeruginosa strains and also 
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their epidemiological surveillance and transmission in the 
hospital environments. The heterogeneity in the ERIC 
genotype results suggests a genetically diverse nature of the 
MDR P. aeruginosa isolates. 
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